AAAAAA
Results: 1076-1100/15678
Authors:
Bayliss, MS
Citation: Ms. Bayliss, Methods in outcomes research in hepatology: Definitions and domains of quality of life, HEPATOLOGY, 29(6), 1999, pp. 3S-6S
Authors:
Cohen, RD
Citation: Rd. Cohen, Validation of health-related quality of life instruments, HEPATOLOGY, 29(6), 1999, pp. 7S-8S
Authors:
Brown, RS
Citation: Rs. Brown, Strategies and pitfalls in quality of life research, HEPATOLOGY, 29(6), 1999, pp. 9S-12S
Authors:
Provenzale, D
Citation: D. Provenzale, Economic considerations for the hepatologist, HEPATOLOGY, 29(6), 1999, pp. 13S-17S
Authors:
Glick, HA
Polsky, D
Citation: Ha. Glick et D. Polsky, Analytic approaches for the evaluation of costs, HEPATOLOGY, 29(6), 1999, pp. 18S-22S
Authors:
Cook, JR
Citation: Jr. Cook, Challenges in economic outcomes research, HEPATOLOGY, 29(6), 1999, pp. 23S-25S
Authors:
Imperiale, TF
Citation: Tf. Imperiale, Meta-analysis: When and how, HEPATOLOGY, 29(6), 1999, pp. 26S-31S
Authors:
Azen, SP
Lapuerta, P
Citation: Sp. Azen et P. Lapuerta, Neural networks in outcomes research, HEPATOLOGY, 29(6), 1999, pp. 32S-35S
Authors:
Matchar, DB
Samsa, GP
Citation: Db. Matchar et Gp. Samsa, Using outcomes data to identify best medical practice: The role of policy models, HEPATOLOGY, 29(6), 1999, pp. 36S-39S
Authors:
Friedman, LS
Citation: Ls. Friedman, The risk of surgery in patients with liver disease, HEPATOLOGY, 29(6), 1999, pp. 1617-1623
Authors:
Dray-Charier, N
Paul, A
Scoazec, JY
Veissiere, D
Mergey, M
Capeau, J
Soubrane, O
Housset, C
Citation: N. Dray-charier et al., Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients, HEPATOLOGY, 29(6), 1999, pp. 1624-1634
Authors:
Mayo, MJ
Jenkins, RN
Combes, B
Lipsky, PE
Citation: Mj. Mayo et al., Association of clonally expanded T cells with the syndrome of primary biliary cirrhosis and limited scleroderma, HEPATOLOGY, 29(6), 1999, pp. 1635-1642
Authors:
Kim, WR
Poterucha, JJ
Wiesner, RH
LaRusso, NF
Lindor, KD
Petz, J
Therneau, TM
Malinchoc, M
Dickson, ER
Citation: Wr. Kim et al., The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis, HEPATOLOGY, 29(6), 1999, pp. 1643-1648
Authors:
Combes, B
Carithers, RL
Maddrey, WC
Munoz, S
Garcia-Tsao, G
Bonner, GF
Boyer, JL
Luketic, VA
Shiffman, ML
Peters, MG
White, H
Zetterman, RK
Risser, R
Rossi, SS
Hofmann, AF
Citation: B. Combes et al., Biliary bile acids in primary biliary cirrhosis: Effect of ursodeoxycholicacid, HEPATOLOGY, 29(6), 1999, pp. 1649-1654
Authors:
Bernard, B
Grange, JD
Khac, EN
Amiot, X
Opolon, P
Poynard, T
Citation: B. Bernard et al., Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: A meta-analysis, HEPATOLOGY, 29(6), 1999, pp. 1655-1661
Authors:
Amodio, P
Del Piccolo, F
Marchetti, P
Angeli, P
Iemmolo, R
Caregaro, L
Merkel, C
Gerunda, G
Gatta, A
Citation: P. Amodio et al., Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests, HEPATOLOGY, 29(6), 1999, pp. 1662-1667
Authors:
Poupon, RE
Bonnand, AM
Chretien, Y
Poupon, R
Citation: Re. Poupon et al., Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis, HEPATOLOGY, 29(6), 1999, pp. 1668-1671
Authors:
Fernandez, M
Bonkovsky, HL
Citation: M. Fernandez et Hl. Bonkovsky, Increased heme oxygenase-1 gene expression in liver cells and splanchnic organs from portal hypertensive rats, HEPATOLOGY, 29(6), 1999, pp. 1672-1679
Authors:
Enomoto, N
Yamashina, S
Kono, H
Schemmer, P
Rivera, CA
Enomoto, A
Nishiura, T
Nishimura, T
Brenner, DA
Thurman, RG
Citation: N. Enomoto et al., Development of a new, simple rat model of early alcohol-induced liver injury based on sensitization of Kupffer cells, HEPATOLOGY, 29(6), 1999, pp. 1680-1689
Authors:
Angeli, P
Volpin, R
Gerunda, G
Craighero, R
Rone, P
Merenda, R
Amodio, P
Sticca, A
Caregaro, L
Maffei-Faccioli, A
Gatta, A
Citation: P. Angeli et al., Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide, HEPATOLOGY, 29(6), 1999, pp. 1690-1697
Authors:
Chaudhry, V
Corse, AM
O'Brian, R
Cornblath, DR
Klein, AS
Thuluvath, PJ
Citation: V. Chaudhry et al., Autonomic and peripheral (sensorimotor) neuropathy in chronic liver disease: A clinical and electrophysiologic study, HEPATOLOGY, 29(6), 1999, pp. 1698-1703
Authors:
Fasani, P
Sangiovanni, A
De Fazio, C
Borzio, M
Bruno, S
Ronchi, G
Del Ninno, E
Colombo, M
Citation: P. Fasani et al., High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors, HEPATOLOGY, 29(6), 1999, pp. 1704-1707
Authors:
Yano, H
Iemura, A
Haramaki, M
Ogasawara, S
Takayama, A
Akiba, J
Kojiro, M
Citation: H. Yano et al., Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines, HEPATOLOGY, 29(6), 1999, pp. 1708-1717
Authors:
Wada, I
Kanada, H
Nomura, K
Kato, Y
Machinami, R
Kitagawa, T
Citation: I. Wada et al., Failure to detect genetic alteration of the mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) gene in hepatocellular carcinomas in Japan, HEPATOLOGY, 29(6), 1999, pp. 1718-1721
Authors:
Yamagata, M
Masaki, T
Okudaira, T
Imai, Y
Shiina, S
Shiratori, Y
Omata, M
Citation: M. Yamagata et al., Small hyperechoic nodules in chronic liver diseases include hepatocellularcarcinomas with low cyclin D1 and Ki-67 expression, HEPATOLOGY, 29(6), 1999, pp. 1722-1729